<
Chinese Pharmaceutical Entrepreneurs Annual Meeting asking tens of billions of pharmaceutical companies to develop pulse development paths
Release time: 2012-09-18 & nbsp & nbsp & nbsp Source: Anonymous

15th,Annual Meeting of the entire industry entrepreneurs,The theme is & ldquo; Asked the 2012 Chinese Pharmaceutical Entrepreneurs Annual Conference at Tianjin Tiansi Group,Well -known enterprises from the domestic and foreign pharmaceutical industry、Government Department、Nearly 500 people of the stake online sports bettingMy stake betting appIndustry Association and other related units jointly explore the industry's future development path,In order to enhance the technical innovation ability, the pulse and support。
 
The background of this annual meeting is,The Chinese pharmaceutical industry & ldquo; 1255 & rdquo;,to 2015,Enterprises with sales revenue of more than 50 billion yuan in the pharmaceutical industry of my country's pharmaceutical industry should reach more than 5,Enterprises with sales revenue reached 10 billion yuan to more than 100,The sales revenue of the top 100 companies should account for more than 50%of the industry。
 
The reporter learned from the annual meeting,In the first half of 2012,my country's pharmaceutical industry realizes sales revenue of 809.4 billion yuan,increased by 19.1%year -on -year,Total profit is 81.07 billion yuan,increased by 17.7%year -on -year。
 
Participants think,Current,The pharmaceutical industry enters the market internationalization、Product standardization、Competitive Bathering Phase。Although the pharmaceutical industry sales and profits in the first half of the year still maintain a double -digit growth rate,But the problem of insufficient innovation ability is still prominent。
 
Wu Yan, deputy director Stake Sports BettingMy stake betting appof the National Food and Drug Administration, said,For more than 30 years of reform and opening up,China's pharmaceutical industry remain strong,But you must be soberly seen,The structural problems brought by extensive development are very prominent。Faced with the increasingly fierce competition in the face of multinational companies,How to improve market competitiveness has become a real issue。
 
& ldquo; Only improve innovation ability,Mastering key technologies can occupy the heights of the industry。& rdquo; Wu Yan said,Now countries around the world can see Chinese products,It is difficult to see Chinese medicine,This is not consistent with the status of China's medical country,It also indicates that China is not a powerful country。The National Food and Drug Administration is recently researching improving approval efficiency、Strengthen clinical research supervision、Strengthening technical guidance and other policy measures,Guidance and encourage innovation,Containment of low level repetition。
 
He Wei, Director of the Department of Science and Education of the Ministry of Health,although generic drugs have a good market,But you must pay attention Stake Sports BettingMy stake betting appto the research of innovative drugs、Development and industrialization,The core of innovation is breakthrough innovation。Enterprises should from the organizers from technological innovation、Direction of the leader。
 
At the annual meeting,Many people will also focus on the Chinese medicine industry in my country。Li Daning, deputy director of the State Administration of Traditional Chinese Medicine,Although Chinese medicine has thousands of years of long history and very deep background,But compared to Western Medicine,There is still a big gap。
 
& ldquo; The core of the modernization strategy of traditional Chinese medicine is inheritance innovation。& rdquo; Researcher Li Boxi said,As an innovative subject,Enterprises must use modern technology and innovative ideas,Vigorously promote technological innovation、Standard Innovation、Brand Innovation、Market Innovation、mechanism innovation、Strategic Innovation。
 
This annual meeting also released the influential & ldquo in the industry; 2012 Chinese pharmaceutical listed companies, the top 20 in the top 20 in competitiveness & rdquo; and & ldquo;,Tzuhili、Yunnan Baiyao and other well -known pharmaceutical companies selected。